BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:GPCRs-targeted drug discovery continues to gain exponential mo
 mentum\, with advances in screening tools\, characterization of dynamic c
 onfirmations and basic GPCR biology\, including orphan receptors. Coupled
  with numerous strategic collaboration and investment\, the GPCR field is
  fuelling for the clinical progression of next-generation small molecules
  and biologics across a spectrum of indications and previously undrugged 
 GPCR targets.\n\nOwing to this\, the Annual GPCRs-Targeted Drug Discovery
  Summit returns for its 3rd year as the world's only and most comprehensi
 ve industry dedicated GPCR forum. Bringing two brand new specialized trac
 ks of content (Target ID and Validation and Hit ID and Optimization)\, do
 n't miss out on your ultimate chance to unite with 100+ GPCR experts devo
 ted to accelerating the discovery of new\, transformative small molecules
  and biologics.\n\nURLs:Tickets:&nbsp\;https://go.evvnt.com/2056320-2?pid
 =185Brochure:&nbsp\;https://go.evvnt.com/2056320-3?pid=185\n\nPrices:Drug
  Developer Pricing - Conference + Focus Day: USD 4297.00\,Drug Developer 
 Pricing - Conference Only: USD 2999.00\,Discounted Pricing - Conference +
  Focus Day: USD 3697.00\,Discounted Pricing - Conference Only: USD 2599.0
 0\,Vendor Pricing - Conference + Focus Day: USD 5197.00\,Vendor Pricing -
  Conference Only: USD 3699.00\n\nSpeakers:&nbsp\;Adnan Sljoka Principal I
 nvestigator RIKEN Center for Integrative Medical Sciences\, Ajay Yekkiral
 a Co-Founder\, Senior Vice President and Head of Discovery Superluminal M
 edicines Inc\, Andreas Busch Senior Scientist - Protein Science Confo The
 rapeutics\, Aurélien Rizk Co-Founder and Chief scientific officer InterAx
  Biotech\, Barbara Cipriani Vice President and Head of Biology Pathios Th
 erapeutics\, Benjamin Chen Managing Partner Panacea Ventures\, Callum Dic
 kson Senior Principal Scientist Novartis AG\, Cheng Zhang Associate Profe
 ssor University of Pittsburgh\, Chris de Graaf Senior Director\, Head of 
 Computational Chemistry Sosei Heptares\, Chris Roth Vice President - Rese
 arch Abilita Therapeutics\, Chris Roth Vice President - Research Abilita 
 Therapeutics\, Clare Doris Chief Operating Officer Cumulus Oncology\, Dal
 e Starkie Director DJS Antibodies/AbbVie\, Edward van Wezel Managing Part
 ner Biogeneration Ventures\, Erik Hembre Associate Vice President Eli Lil
 ly and Co.\, Faiz Ahmad Mohammed Senior Advisor Eli Lilly and Co.\, Graem
 e Milligan Gardiner Professor of Biochemistry University of Glasgow\, Iri
 na Tikhonova Reader in Molecular Modelling Queen's University Belfast\, J
 ean-Philippe Fortin Research Fellow Pfizer\, Josephine (Pina) Cardarelli 
 Chief Scientific Officer and President of US Site Operations GPCR Therape
 utics\, Joshua Ziarek Associate Professor of Pharmacology Northwestern Un
 iversity\, Laetitia Comps-Agrar Senior Principal Scientist - Biochemical 
 and Cellular Pharmacology Genentech\, Mike Goguen Founder and Managing Di
 rector Two Bear Capital\, Niklas Larsson Principal Scientist AstraZeneca\
 , Oliver Hartley Vice President - Drug Discovery Orion Biotechnology\, Pe
 ter McNamara Chief Scientific Officer Tectonic Therapeutic\, Reza Vafabak
 hsh Assistant Professor Northwestern University\, Robin Löving Chief Scie
 ntific Officer Salipro Biotech AB\, Seungil Han Research Fellow and Head 
 of Cryo-EM Structural Biology Lab Pfizer\, Shu-Chen Lu Scientific Associa
 te Director Amgen Inc.\, Stacey Southall Vice President\, Head of Platfor
 m Sosei Heptares\, Stephan Schann VP Research Domain Therapeutics\, Steve
  Gardner Chief Executive Officer PrecisionLife Ltd.\, Yue Liu Associate D
 irector Generate Biomedicines\, Inc\, Zoe Hughes Vice President and Head 
 of Biology Gilgamesh Pharmaceutical\n\nCategory:&nbsp\;Conferences | Scie
 nce\, Health and Medicine | Pharmaceuticals | Drug Discovery\n\nDate and 
 Time:&nbsp\;5th March 2024 at 8:00 am to 7th March 2024 at 5:00 pm\n
DTEND:20240307T170000
DTSTAMP:20260512T220335Z
DTSTART:20240305T080000
LOCATION:Hilton Boston Back Bay\, 40\, Dalton Street\, Boston\, Massachuse
 tts\, 02115\,
SEQUENCE:0
SUMMARY:GPCRs-targeted drug discovery continues to gain exponential moment
 um\, with advances in screening tools\, characterization of dynamic confi
 rmations a...
UID:290b5c8c-46ba-429d-98be-6c527c286475
END:VEVENT
END:VCALENDAR